Monday, 5 October 2009
Ballroom East (CTICC)
Contraception and Beyond: Evidence-based Indications for LNG-IUS
1. Wider Use of Intrauterine Contraception - David Grimes
2. The LNG-IUS in Heavy Menstrual Bleeding: First-line Treatment Based on Comprehensive Clinical Data - Anita Nelson 3. Safety and Efficacy of Consecutive Use of the LNG-IUS - Confirmed by a New Study -Kristina Gemzell-Danielsson Symposium sponsored by Bayer Schering Pharma
Ballroom West (CTICC)
The Role of GARDASIL™ in Reducing the Global Burden of Cervical Cancer and

Other HPV-Related Diseases
1. Opening Remarks – Lynette Denny, South Africa
2. Global HPV Epidemiology and Burden of Disease - Lynette Denny, South Africa3. Gardasil Efficacy and Recent Clinical Data - Suzanne M. Garland, Australia 4. MSD’s Commitment: Access to Gardasil in the Developing World - Carlos Sattler, USA Symposium sponsored by MSD
Tuesday, 6 October 2009
Ballroom East (CTICC)
Innovation in Contraception
1. Ethinylestradiol 20mcg/Drospirenone 3mg Administered in a 24/4 Regimen: A New OC
Goes Beyond Contraception - Joachim Marr and Lorraine Dennerstein
2. A New OC Concept with Additional Benefit - Wolfgang Holzgreve and Klaus Pietrzik Symposium sponsored by Bayer Schering Pharma
Ballroom West (CTICC)
Overactive Bladder: TIME to take notice
Chairman’s Introduction
1. The Burden and Implications of OAB – Linda Cardozo, UK2. Initial Diagnosis and Assessment of Women with LUTS - Mickey Karram, USA3. Making Sure We Understand Our Patient’s Needs – Peter de Jong, South Africa 4. Ensuring Successful Management with Pharmacotherapy - Willy Davilla, USA Symposium sponsored by Astellas Pharma
Wednesday, 7 October 2009
Ballroom East (CTICC)
Evolution of a Revolution: Introducing a New Class of Oral Contraceptive
1. Introducing E2V/DNG - Ian Fraser2. E2V/DNG: Contraceptive Efficacy and Safety Data - Jeffrey T. Jensen 3. First Experience with the Estradiol Based Combined Oral Contraceptive E2V/DNG - Diana Mansour Symposium sponsored by Bayer Schering Pharma
Ballroom West (CTICC)
Effective Solutions for Enhanced Obstetric Management
1. New Ultrasound Technologies in Assisted Reproductive Medicine SonoAVC - Nick Raine
Fenning, Nottingham, UK
2. Enhancing the Monitoring Experience from Antepartum through to Postpartum - Philippe Barjot, Caen, France 3. Improving Obstetric Workflow, Archiving and Reporting - Philippe Barjot, Caen, France Symposium sponsored by GE Healthcare
Thursday, 8 October 2009
Ballroom East (CTICC)
Improving Women's Healthcare - a Contemporary View
Chair: Jennifer Blake
1. Progestins - An Important Versatile Class – Peter Rogers
2. Specialised Progestins I - Dienogest in Endometriosis - Alfred Mueck3. Specialised Progestins II – Drospirenone in Menopause - Tommaso Simoncini Symposium sponsored by Bayer Schering Pharma
Ballroom West (CTICC)
Cervarix®: Focusing on the Global Needs of Cervical Cancer Vaccination
1. Welcome and Introduction – Anne Szarewski, UK and Hugues Bogaerts, Belgium
2. The Relevance of the HPV Type Distribution in Cervical Cancer – F. Xavier Bosch, Spain3. Understanding the Immunological Potential of HPV Vaccines – Peter L. Stern, UK4. Cervarix®: The Benefits to Girls and Women: From Clinical Trials to Clinical Practice – Anne Symposium sponsored by GlaxoSmithKline


Eccezionale soggiorno a Cipro Nord, la nuova stella del Mediterraneo, dall’ 11 al 19 giugno A solo € 570,00 (min. 40 partecipanti) Questo incredibile prezzo è possibile grazie ad un sostanzioso contributo del governo Cipriota, atto a incentivare il turismo nell’Isola Le spiagge ancora libere ed incontaminate, deserte con un mare stupendo, l’acqua limpida e calda, la sabbia bia

Par cremeb 03-2014

PARECER CREMEB Nº 03/14 (Aprovado em Sessão Plenária de 21/01/2014) EXPEDIENTE CONSULTA Nº 010.229/13 ASSUNTO: I nterrupção de gestação com autorização legal de feto com outras más formações RELATOR: Cons. José Augusto da Costa EMENTA: A autorização judicial referenda a interrupção da gravidez. A utilização de métodos que provoquem a morte de fetos mal

© 2010-2018 Modern Medicine